Back to Search
Start Over
Allelic and Genotype Frequencies of CYP2B6 ∗ 2 (64C > T) and CYP2B6 ∗ 3 (777C > A) in Three Dominant Ethnicities of the Iranian Population.
- Source :
-
Genetics research [Genet Res (Camb)] 2023 Feb 09; Vol. 2023, pp. 8283470. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Background: Cytochrome P450 complex plays a key role in drug metabolism. CYP2B6 has an essential part in Cytochrome P450 complex metabolism. This study aims to determine the allelic distribution of CYP2B6 <superscript>∗</superscript> 2 and CYP2B6 <superscript>∗</superscript> 3 in three main Iranian ethnicities: Fars, Turk, and Kurd.<br />Methods: The study was conducted on 174 unrelated healthy volunteers from three main Iranian ethnicities. After DNA extraction from peripheral blood samples, genotyping of CYP2B6 <superscript>∗</superscript> 2 and <superscript>∗</superscript> 3 was performed using tetra ARMS and ARMS PCR, respectively.<br />Results: The average age of 174 cases was 40.69 ± 11.87 (mean ± SD) and 39.06 ± 11.63 (mean ± SD) for males and females. In the CYP2B6 <superscript>∗</superscript> 2 variant, the genotyping frequency of wild type (C/C), heterozygous (C/T), and homozygous mutant (T/T) was 8.7%, 86%, and 5.2%, respectively. The CYP2B6 <superscript>∗</superscript> 2 (c.64C > T) allele frequency was 48.2% (95% CI: (37.8-58.6)). In the CYP2B6 <superscript>∗</superscript> 3 variant, the frequency of wild type (C/C), heterozygous (C/T), and homozygous mutant (T/T) was 75.3%, 11%, and 13.6%, respectively. The CYP2B6 <superscript>∗</superscript> 3 (c.777C > A) allelic frequency was 19.1% (95% CI: (17.5-20.7)).<br />Conclusion: Allelic distribution in three main Iranian ethnicities, i.e., Turk, Kurd, and Fars, is remarkably higher than that in other populations, even that in Southern Iran. High frequencies of CYP2B6 <superscript>∗</superscript> 2 and <superscript>∗</superscript> 3 in the Iranian population highly affect drug responsiveness. Understanding such variability could help to increase drug efficacy and reduce its toxicity.<br />Competing Interests: The authors declare that they have no conflicts of interest.<br /> (Copyright © 2023 Armin Khavandegar et al.)
Details
- Language :
- English
- ISSN :
- 1469-5073
- Volume :
- 2023
- Database :
- MEDLINE
- Journal :
- Genetics research
- Publication Type :
- Academic Journal
- Accession number :
- 36817260
- Full Text :
- https://doi.org/10.1155/2023/8283470